First patient dosed in YK012 trial-the world's first TCE therapy for primary membranous nephropathy
May 29, 2025 15:49 HKT |  |
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully
May 28, 2025 19:57 HKT |  |
|
Modern Dental Group's Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium
May 28, 2025 16:44 HKT |  |
|
International Healthcare Week kicks off today
May 26, 2025 18:27 HKT | |
|
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
May 20, 2025 21:00 HKT |  |
|
TruMerit Hails Release of WHO's State of the World's Nursing Report
May 16, 2025 07:00 HKT |  |
|
International Medical and Healthcare Week Highlights Hong Kong's Strengths in Medical and Innovation
May 15, 2025 12:33 HKT | |
|
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited
May 14, 2025 15:00 HKT |  |
|
Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025 from 100,000+ Registrations
May 08, 2025 16:54 HKT |  |
|
Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D
May 06, 2025 20:00 HKT |  |
|
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
May 05, 2025 19:30 HKT |  |
|
Azurite Medical and Wellness Launches Revolutionary Luxury Surgical Retreat Concept in Global Medical Tourism Market
Apr 29, 2025 02:09 HKT |  |
|
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Apr 25, 2025 15:49 HKT |  |
|
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
Apr 24, 2025 18:43 HKT |  |
|
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 22, 2025 10:16 HKT | |
|
CIRC: Attained a New High in Fiscal Year 2024
Apr 22, 2025 09:52 HKT | |
|
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
Apr 15, 2025 08:00 HKT | |
|
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong
Apr 03, 2025 17:30 HKT |  |
|
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Apr 03, 2025 17:00 HKT |  |
|
Fosun's Stable Fundamentals Support its Clear Growth Path
Apr 01, 2025 11:14 HKT | |
|